Shinpoong Pharmaceutical Co Ltd
KRX:019170
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Shinpoong Pharmaceutical Co Ltd
Research & Development
Shinpoong Pharmaceutical Co Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Shinpoong Pharmaceutical Co Ltd
KRX:019170
|
Research & Development
-₩14.6B
|
CAGR 3-Years
21%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
|
Yuhan Corp
KRX:000100
|
Research & Development
-₩198.2B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-18%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Research & Development
-₩169.7B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Research & Development
-₩195.8B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-2%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Research & Development
-₩8.7B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
17%
|
CAGR 10-Years
-9%
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Research & Development
-₩5.7B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
Shinpoong Pharmaceutical Co Ltd
Glance View
Shinpoong Pharmaceutical Co. Ltd. engages in the manufacture and sales of pharmaceutical products. The company is headquartered in Ansan, Gyeonggi-Do. The firm's product portfolio consists of antibiotics, cardiovascular drugs, anti-cancer drugs, psychoneurotic drugs, antirheumatic drugs, antidiabetics, antifungal agents, antihistamines, antiviral agents, benign prostatic hyperplasia (BPH) drugs and trichogens. The firm also provides active pharmaceutical ingredients (APIs) synthesized by the Company, including non-steroidal anti-inflammatory drugs (NSAIDs), cardiovascular drugs, anti-ulcer drugs, respiratory drugs, antispasmodics drugs and others. The firm distributes its products within domestic market and to overseas markets.
See Also
What is Shinpoong Pharmaceutical Co Ltd's Research & Development?
Research & Development
-14.6B
KRW
Based on the financial report for Sep 30, 2025, Shinpoong Pharmaceutical Co Ltd's Research & Development amounts to -14.6B KRW.
What is Shinpoong Pharmaceutical Co Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
-17%
Over the last year, the Research & Development growth was 50%. The average annual Research & Development growth rates for Shinpoong Pharmaceutical Co Ltd have been 21% over the past three years , -17% over the past five years .
